Showing results (201-210 of 4,868) with videos related to

Sort By:
Pageof 487
Urologic Oncology|March 4, 2020
Mutation signatures to Pan-Cancer Atlas: Investigation of the genomic landscape of muscle-invasive bladder cancerLauren Folgosa Cooley, Alexander P Glaser, Joshua J Meeks
Urologic Oncology|March 7, 2020
Topographic distribution of first landing sites of lymphatic metastases from patients with renal cancerTeele Kuusk, Patricia Zondervan, Brunolf Lagerveld, et al.
Urologic Oncology|March 7, 2020
The pretreatment neutrophil-to-lymphocyte ratio is a novel biomarker for predicting clinical responses to pembrolizumab in platinum-resistant metastatic urothelial carcinoma patientsKoichiro Ogihara, Eiji Kikuchi, Keisuke Shigeta, et al.
Urologic Oncology|March 7, 2020
Microtubule-associated protein tau (MAPT) is a promising independent prognostic marker and tumor suppressive protein in clear cell renal cell carcinomaXiangrui Han, Yohei Sekino, Takashi Babasaki, et al.
Urologic Oncology|March 12, 2020
Netrin-1: A new promising diagnostic marker for muscle invasion in bladder cancerRanda El-Gamal, Naglaa Mokhtar, Bedeir Ali-El-Dein, et al.
Urologic Oncology|February 1, 2020
Improving postoperative quality of care in germ cell tumor patients: Does scheduled alvimopan, acetaminophen, and gabapentin improve short-term clinical outcomes after retroperitoneal lymph node dissection?Adam C Calaway, Richard S Foster, Yan Tong, et al.
Urologic Oncology|January 21, 2020
Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional datasetAlessandro Veccia, Alessandro Antonelli, Andrea Minervini, et al.
Urologic Oncology|March 30, 2020
Bioptic intraprostatic chronic inflammation predicts adverse pathology at radical prostatectomy in patients with low-grade prostate cancerFrancesca Sanguedolce, Ugo Giovanni Falagario, Pietro Castellan, et al.
Urologic Oncology|January 21, 2019
High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladderYing-En Lee, Ti-Chun Chan, Yu-Feng Tian, et al.
Urologic Oncology|January 26, 2019
ERG expression can predict the outcome of docetaxel combinedwith androgen deprivation therapy in metastatic hormone-sensitiveprostate cancerZsófia Küronya, Farkas Sükösd, Linda Varga, et al.
Pageof 487